111 related articles for article (PubMed ID: 7688463)
1. Keratin intermediate filament expression in astrocytic neoplasms: analysis by immunocytochemistry, western blot, and northern hybridization.
Cosgrove MM; Rich KA; Kunin SA; Sherrod AE; Martin SE
Mod Pathol; 1993 May; 6(3):342-7. PubMed ID: 7688463
[TBL] [Abstract][Full Text] [Related]
2. Expression of non-glial intermediate filament proteins in gliomas.
Hirato J; Nakazato Y; Ogawa A
Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytokeratins in gliomas.
Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
[TBL] [Abstract][Full Text] [Related]
4. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of GFAP, vimentin and cytokeratins in GL-15 glioblastoma cell line.
Perzelcová A; Máciková ; Tardy M; Mráz P; Steno J; Bízik I
Neoplasma; 2000; 47(6):362-6. PubMed ID: 11263860
[TBL] [Abstract][Full Text] [Related]
6. Glial fibrillary acidic protein expression in pleomorphic adenoma, chordoma, and astrocytoma. A comparison of three antibodies.
Wittchow R; Landas SK
Arch Pathol Lab Med; 1991 Oct; 115(10):1030-3. PubMed ID: 1654872
[TBL] [Abstract][Full Text] [Related]
7. CD44 expression in astrocytic tumors.
Ylagan LR; Quinn B
Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
[TBL] [Abstract][Full Text] [Related]
8. Intermediate filament expression in astrocytic neoplasms.
Cosgrove M; Fitzgibbons PL; Sherrod A; Chandrasoma PT; Martin SE
Am J Surg Pathol; 1989 Feb; 13(2):141-5. PubMed ID: 2464954
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study of S-phase cells in human gliomas].
Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 17 allelic loss in astrocytic tumors and its clinico-pathologic implications.
Muhammad AK; Yoshimine T; Maruno M; Tokiyoshi K; Takemoto O; Ninomiya H; Hayakawa T
Clin Neuropathol; 1997; 16(4):220-6. PubMed ID: 9266149
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin immunoreactivity in malignant fibrous histiocytoma and spindle cell tumors: comparison between frozen and paraffin-embedded tissues.
Litzky LA; Brooks JJ
Mod Pathol; 1992 Jan; 5(1):30-4. PubMed ID: 1371872
[TBL] [Abstract][Full Text] [Related]
14. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
Korshunov AG; Sycheva RV
Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
[TBL] [Abstract][Full Text] [Related]
15. Expression and release of CD14 in astrocytic brain tumors.
Deininger MH; Meyermann R; Schluesener HJ
Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
[TBL] [Abstract][Full Text] [Related]
16. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing.
Johnson TL; Zarbo RJ; Lloyd RV; Crissman JD
Mod Pathol; 1988 May; 1(3):216-23. PubMed ID: 2467285
[TBL] [Abstract][Full Text] [Related]
17. Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity.
Abaza MS; Shaban F; Narayan RK; Atassi MZ
Anticancer Res; 1998; 18(2B):1333-40. PubMed ID: 9615812
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.
Fuchs U; Kivelä T; Summanen P; Immonen I; Tarkkanen A
Am J Pathol; 1992 Jul; 141(1):169-81. PubMed ID: 1378696
[TBL] [Abstract][Full Text] [Related]
19. Glial cells of the lamprey nervous system contain keratin-like proteins.
Merrick SE; Pleasure SJ; Lurie DI; Pijak DS; Selzer ME; Lee VM
J Comp Neurol; 1995 May; 355(2):199-210. PubMed ID: 7541809
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]